Robert Trenschel

Grant Thornton LLP provides accounting, tax and business consulting services. It offers advisory, business consulting, business risk, enterprise technology and innovation, transaction services, data analytics, cyber risk, and data integrity services. The firm serves the construction, real estate and hospitality, consumer and industrial products, energy, financial services, health care and life sciences, not for profit organizations, private equity, public sector, and technology industries. The company was founded in 1924 and is headquartered in Chicago, IL.

University of Southern California is a private research university that mainly offers undergraduate, graduate & other higher education. The university was founded in 1880 and is headquartered in Los Angeles, CA.

Part of Prime Healthcare Holdings, Inc., Centinela Hospital Medical Center operates an acute care hospital. The company is based in Inglewood, CA. Centinela Hospital Medical Center was acquired by Prime Healthcare Services, Inc. from Centinela Freeman HealthSystem on October 31, 2007.

Grant Thornton International Ltd. engages in the provision of business advisory services. It offers business risk and consulting, business process solutions, cybersecurity, forensic and investigation, mergers and acquisitions, recovery and reorganization, transactional advisory, and valuations services. The company was founded in 1980 and is headquartered in London, the United Kingdom.

Billings Clinic provides health care services. It offers audiology, immunology, assited living, clinical services, emergency services, eye center, obstetrics and gynecology, oncology, ophthalmology, occupational medicine, and neurology. The company was founded in 1911 and is headquartered in Billings, MT.

Alphatec Spine, Inc. is focused on the design, development, manufacturing, and marketing of products for the surgical treatment of spine disorders, with a focus on treating condition affecting the aging spine. The firms product portfolio and pipeline include spinal disorder products and systems. The company was founded in 1990 and is headquartered in Carlsbad, CA.

Ernst & Young LLP engages in the provision of accounting services. The company was founded on April 6, 2001 and is headquartered in London, the United Kingdom.

Mid-Columbia Medical Center provides healthcare services. It provides services intended to address patient's emotional, spiritual, intellectual and environmental concerns in addition to their physical needs. The firm as a hospital with its affiliates offers medical, cancer, home care, and therapy services. The company was founded in 1944 and is headquartered in Dalles, OR.

Health Current operates as a health information exchange. The firm conducts programs that support health information technology. The company was founded in 2007 and is headquartered in Phoenix, AZ.

SAFE-BioPharma Association provides technological services. It specializes in trust framework provider, issuers and cross certification. The firm offers digital signatures, E submission, E contracting, authentication services. The company was founded in 2006 and is headquartered in Ormond Beach, FL.

Proove Biosciences, Inc. provides genetic testing services. It engages in the research, investigation and development of patent-protected precision medicine profiles that combine genetic and clinical data into reports to help clinicians individualize medicine selection and dosing for chronic pain. The company was founded by Brian Meshkin in 2009 and is headquartered in Irvine, CA.

Exonics Therapeutics, Inc. develops therapies for neuromuscular diseases. It also develops gene editing technologies like CRISPR/Cas9 to permanently correct the majority of duchenne muscular dystrophy mutations. The company was founded by Eric N. Olson in February 2017 and is headquartered in Cambridge, MA.

T1D Exchange is a nonprofit organization that was established in 2010 with initial and ongoing support from the Leona M. and Harry B. Helmsley Charitable Trust. T1D Exchange is based in Boston, MA. The non-profit company is dedicated to improving outcomes for the entire T1D population through real-world evidence and clinical data collection and analysis. T1D Exchange is a leading provider of real-world evidence, identifying gaps in data and redefining best practices to improve the lives of those living with T1D. The company actively supports quality improvement and innovation through its quality improvement collaborative, patient registry, and data-oriented research services. David Walton has been the CEO of the company since 2018.

Caraway Therapeutics, Inc. provides heathcare services. The company was founded by Timothy Harris, Wade Harper ,Ivan Dikic ,Tony Hyman and is headquartered in Cambridge, MA.

Forendo Pharma Oy provides novel pharmaceutical treatments for endometriosis and low testosterone levels. Its product fispemifene is the first selective estrogen receptor modulator designed only for men, which helps for the treatment of symptoms of low testosterone, in phase II clinical studies in men with secondary hypogonadism; fispemifene has normalized the low testosterone levels. Its 17HSD1-inhibitor focuses on endometriosis, is a potent and selective lead compounds demonstrated in vivo proof of efficacy in disease model of endometriosis. The company was founded by Risto Arvo Sakari Lammintausta in 2013 and is headquartered in Turku, Finland.

CONNECT creates and scales companies in the technology and life sciences sectors. It creates an environment in which entrepreneurs and C-suite executives have access to the people, capital, and technology resources. The organization was founded in 1985 and is headquartered in San Diego, CA.

Nashville Technology Council is a non-profit organization, with interest on growth and influence in middle Tennessee’s tech industry. It focuses on the need in Nashville for better paying jobs and improved capital investment in technology start-ups. The company was founded in 1999 and is headquartered in Nashville, TN.

Viracta Subsidiary, Inc. engages in the development of proprietary viral gene activation therapy to address cancers associated with the Epstein-Barr virus. Its platform is designed as a targeted approach to treat a range of viral-associated cancers and other serious diseases. The company was founded by Ronald J. Berenson, Douglas V. Faller, George C. Hillman, Thalia Papayannopoulou, Susan P. Perrine, George Stamatoyannopoulos, and Robert Williams and is headquartered in Cardiff, CA.